FDA Issues Canine Anthelmintic Guidance to Support Global Veterinary Drug Reviews
June 27, 2026
June 27, 2026
WASHINGTON, June 27 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has issued final guidance for industry outlining study design recommendations for evaluating the effectiveness of anthelmintic drugs in dogs, with the aim of supporting broader international acceptance of veterinary drug data.
The guidance, announced in a notice published in the Federal Register, updates recommendations developed through the International Cooperation on Harmo . . .
The guidance, announced in a notice published in the Federal Register, updates recommendations developed through the International Cooperation on Harmo . . .
